Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 163

The DOI matches its Crossref record.

The C‐Terminal Domain V of Perlecan Promotes β1 Integrin‐Mediated Cell Adhesion, Binds Heparin, Nidogen and Fibulin‐2 and Can be Modified by Glycosaminoglycans

Brown, Judith C., Sasaki, Takako, Göhring, Walter, Yamada, Yoshihiko, Timpl, Rupert · 1997 · European Journal of Biochemistry

Abstract

Domain V of the major basement‐membrane proteoglycan perlecan, a domain which consists of three laminin type G (LG) and four epidermal‐growth‐factor‐like (EG) modules, was obtained in recombinant form by transfecting embryonic kidney cells with an episomal expression vector. A major 90‐kDa fragment V was obtained together with fragments Va (74 kDa) and Vb (26 kDa) which were generated by endogenous proteolysis in front of the most C‐terminal LG module. All three fragments bound to a heparin affinity column and could be displaced at a moderate (0.2 M) NaCl concentration. Rotary‐shadowing electron microscopy demonstrated a three‐globule structure for fragment V. Fragment V also showed a strong immunological cross‐reaction with tissue‐derived perlecan, indicating that it was folded into a native structure. A further, larger fragment, Vc, was apparently substituted with heparan sulphate and/or chondroitin sulphate chains and failed to bind to heparin. Fragment V but not fragment Vc promoted a distinct adhesion of several cell lines and this could be blocked by antibodies against the integrin β1 chain. This domain may, however, represent only one of several cell‐adhesive sites of perlecan. The recombinant perlecan fragment V bound in surface plasmon resonance assays to fibulin‐2, laminin‐nidogen complex, nidogen and two nidogen fragments. This indicated two different nidogen‐binding epitopes on perlecan domain V with about a 10‐fold difference in their affinities (Kd= 0.05–0.2 μM and about 2 μM). Perlecan domain V therefore seems to participate in the supramolecular assembly and cell connections of basement membranes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1432-1033.1997.t01-1-00039.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 163

Metadata

Authors
Brown, J. C., Sasaki, T., Göhring, W., Yamada, Y., & Timpl, R.
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1997-11
Volume
250
Issue
1
Pages
39-46
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
OpenAlex
W2083503468
Cited by
163
References
0
FWCI
2.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The C‐Terminal Domain V of Perlecan Promotes β1 Integrin‐Mediated Cell Adhesion, Binds Heparin, Nidogen and Fibulin‐2 and Can be Modified by Glycosaminoglycans. https://app.cochat.ai/papers/10.1111/j.1432-1033.1997.t01-1-00039.x
The paper
Brown, J. C., Sasaki, T., Göhring, W., Yamada, Y., & Timpl, R. (1997). The C‐Terminal Domain V of Perlecan Promotes β1 Integrin‐Mediated Cell Adhesion, Binds Heparin, Nidogen and Fibulin‐2 and Can be Modified by Glycosaminoglycans. European Journal of Biochemistry. https://doi.org/10.1111/j.1432-1033.1997.t01-1-00039.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.